Patent details
EP2695609 Title: Oral formulations of cytidine analogs and methods of use thereof
Basic Information
- Publication number:
- EP2695609
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Revoked
- Application number:
- EP131827214
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Oral formulations of cytidine analogs and methods of use thereof
- French Title of Invention:
- Formulations orales d'analogues de cytidine et leurs procédés d'utilisation
- German Title of Invention:
- Orale Formulierungen von Cytidinanaloga und Verfahren zur Verwendung davon
- SPC Number:
Dates
- Filing date:
- 14/05/2009
- Grant date:
- 11/12/2019
- EP Publication Date:
- 12/02/2014
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 11/12/2019
- EP B1 Publication Date:
- 11/12/2019
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 14/05/2029
- Renunciation date:
- Revocation date:
- 03/06/2025
- Annulment date:
Owner
- From:
- 01/03/2024
- Name:
- Celgene Corporation
- Address:
- Route 206 & Province Line Road, Princeton, NJ 08543, United States (US)
History of Owners
- From:
- 04/12/2019
- To:
- 01/03/2024
- Name:
- CELGENE CORPORATION
- Address:
- 86 Morris Avenue, Summit, NJ 07901, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 13/12/2019
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- Etter, Jeffrey B.
- Address:
- United States (US)
2
- Name:
- Backstrom, Jay T.
- Address:
- United States (US)
3
- Name:
- Lai, Mei
- Address:
- United States (US)
Priority
1
- Priority Number:
- 53609 P
- Priority Date:
- 15/05/2008
- Priority Country:
- United States (US)
2
- Priority Number:
- 201145 P
- Priority Date:
- 05/12/2008
- Priority Country:
- United States (US)
3
- Priority Number:
- 157875 P
- Priority Date:
- 05/03/2009
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 9/20; A61K 9/28; A61K 31/7068;
Publication
Bulletin
- Bulletin Heading:
- VRV
- Bulletin edition number:
- 2025/09
- Publication date:
- 05/08/2025
- Description:
- Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates
European Patent Bulletin
1
- Issue number:
- 201950
- Publication date:
- 11/12/2019
- Description:
- Grant (B1)
2
- Issue number:
- 202042
- Publication date:
- 14/10/2020
- Description:
- Opposition procedure started
3
- Issue number:
- 202532
- Publication date:
- 06/08/2025
- Description:
- Revocation of the European patent
4
- Issue number:
- 202002
- Publication date:
- 08/01/2020
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
5
- Issue number:
- 202414
- Publication date:
- 03/04/2024
- Description:
- Change of owner's name or address
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 29/04/2025
- Last Annual Fee Paid Number:
- 17
- Last Annual Fee Paid Amount:
- 246 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 13/12/2019 | Power Of Attorney | 1 |
| 13/12/2019 | Outgoing Correspondence | 1 |